China
Africa
Explore chapters and articles related to this topic
Yellow Fever
Published in James H. S. Gear, CRC Handbook of Viral and Rickettsial Hemorrhagic Fevers, 2019
Wilbur G. Downs, Robert E. Shope
Later in the course of disease, consideration must be given to infectious and serum hepatitis, Weil’s disease, carbon tetrachloride poisoning, dengue hemorrhagic fever, tick-borne relapsing fever, malaria, or blackwater fever, in addition to miscellaneous conditions that have jaundice with fever or hemorrhagic manifestations with fever. Several virus diseases have been described in which hemorrhagic features have been noted, at least in some cases, including dengue, Kyasanur Forest disease, Argentine hemorrhagic fever, Bolivian hemorrhagic fever, Lassa fever, Marburg disease, Ebola fever, Rift Valley fever and Crimean-Congo hemorrhagic fever. There can be little doubt that in Africa, Asia and Southeast Asia, and South America, in regions which have been inadequately explored medically, there may exist still other diseases which could be mistaken for yellow fever.
Ribavirin
Published in M. Lindsay Grayson, Sara E. Cosgrove, Suzanne M. Crowe, M. Lindsay Grayson, William Hope, James S. McCarthy, John Mills, Johan W. Mouton, David L. Paterson, Kucers’ The Use of Antibiotics, 2017
Emily Woolnough, Amanda Wade, Joe Sasadeusz
One patient with confirmed and one with suspected Bolivian hemorrhagic fever (caused by Machupo and Chapare viruses, members of the Tacaribe serocomplex, family Arenaviridae) were successfully treated with intravenous ribavirin (Kilgore et al., 1997).
Arenaviruses and Neurovirology
Published in Sunit K. Singh, Daniel Růžek, Neuroviral Infections, 2013
Bolivian hemorrhagic fever was recognized in 1959 among patients in the town of San Joaquin in the Beni department of northeast Bolivia involving about 1000 cases (Tesh et al. 1999) and the Machupo virus first isolated in 1963. Several outbreaks of the disease occurred in the 1960s, but subsequently, the disease has been recognized only sporadically in the endemic area.
Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases
Published in Expert Review of Anti-infective Therapy, 2022
The first case of Human Immunodeficiency Virus (HIV) infection was identified in 1960s [2]. Afterward, hantaviruses were described as the etiological agent of hemorrhagic fever with renal syndrome [3]. Sporadic cases of Lassa fever, Argentine hemorrhagic fever, and Bolivian hemorrhagic fever had also been a major concern for public health [4]. Since the emergence of the Nipah virus (NiV), this virus has reappeared on different occasions causing severe infections [5]. In 2002, the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) was identified, and, in 2009, the H1N1 influenza virus showed high community transmission yet low mortality [6,7]. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was firstly identified in 2012 and has also caused outbreaks, with its severe cases possibly to succumb to fatal outcomes [8]. The 2013–2015 West African epidemic has been characterized as the most geographically extensive, most fatal, and longest lasting epidemic in Ebola’s history [9]. Zika virus was evident from 2007, but resulted to a Brazilian pandemic outbreak in 2015 [10]. In 2019, SARS Coronavirus 2 (SARS-CoV-2) was identified and led to the current pandemic, while nowadays the Monkeypox virus is again evident [11].